166 related articles for article (PubMed ID: 14608900)
1. beta-Catenin is expressed aberrantly in tumors expressing shadow cells. Pilomatricoma, craniopharyngioma, and calcifying odontogenic cyst.
Hassanein AM; Glanz SM; Kessler HP; Eskin TA; Liu C
Am J Clin Pathol; 2003 Nov; 120(5):732-6. PubMed ID: 14608900
[TBL] [Abstract][Full Text] [Related]
2. Beta-catenin expression in benign and malignant pilomatrix neoplasms.
Hassanein AM; Glanz SM
Br J Dermatol; 2004 Mar; 150(3):511-6. PubMed ID: 15030335
[TBL] [Abstract][Full Text] [Related]
3. Ghost cells in pilomatrixoma, craniopharyngioma, and calcifying cystic odontogenic tumor: histological, immunohistochemical, and ultrastructural study.
Rumayor A; Carlos R; Kirsch HM; de Andrade BA; Romañach MJ; de Almeida OP
J Oral Pathol Med; 2015 Apr; 44(4):284-90. PubMed ID: 25047924
[TBL] [Abstract][Full Text] [Related]
4. Expression of hard alpha-keratins in pilomatrixoma, craniopharyngioma, and calcifying odontogenic cyst.
Kusama K; Katayama Y; Oba K; Ishige T; Kebusa Y; Okazawa J; Fukushima T; Yoshino A
Am J Clin Pathol; 2005 Mar; 123(3):376-81. PubMed ID: 15716233
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of hair and epithelial keratins and transcription factors HOXC13, LEF1, and beta-catenin in a malignant pilomatricoma: a histological and immunohistochemical study.
Cribier B; Worret WI; Braun-Falco M; Peltre B; Langbein L; Schweizer J
J Cutan Pathol; 2006 Jan; 33(1):1-9. PubMed ID: 16441405
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of beta-catenin and adenomatous polyposis coli in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2005 Aug; 34(7):401-6. PubMed ID: 16011608
[TBL] [Abstract][Full Text] [Related]
7. Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation.
Sekine S; Takata T; Shibata T; Mori M; Morishita Y; Noguchi M; Uchida T; Kanai Y; Hirohashi S
Histopathology; 2004 Dec; 45(6):573-9. PubMed ID: 15569047
[TBL] [Abstract][Full Text] [Related]
8. Beta-catenin gene alterations in a variety of so-called calcifying odontogenic cysts.
Ahn SG; Kim SA; Kim SG; Lee SH; Kim J; Yoon JH
APMIS; 2008 Mar; 116(3):206-11. PubMed ID: 18377586
[TBL] [Abstract][Full Text] [Related]
9. CK13 in craniopharyngioma versus related odontogenic neoplasms and human enamel organ.
el-Sissy NA; Rashad NA
East Mediterr Health J; 1999 May; 5(3):490-502. PubMed ID: 10793828
[TBL] [Abstract][Full Text] [Related]
10. Basal cell carcinoma with matrical differentiation: a case study with analysis of beta-catenin.
Haskell HD; Haynes HA; McKee PH; Redston M; Granter SR; Lazar AJ
J Cutan Pathol; 2005 Mar; 32(3):245-50. PubMed ID: 15701088
[TBL] [Abstract][Full Text] [Related]
11. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
Bhatia N; Spiegelman VS
Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
[TBL] [Abstract][Full Text] [Related]
12. [Beta-catenin mutations in a common skin cancer: pilomatricoma].
Durand M; Molès JP
Bull Cancer; 1999 Sep; 86(9):725-6. PubMed ID: 10519964
[TBL] [Abstract][Full Text] [Related]
13. Differentiation and apoptosis in pilomatrixoma.
Ishige T; Kikuchi K; Miyazaki Y; Hara H; Yoshino A; Terui T; Katayama Y; Kusama K; Nemoto N
Am J Dermatopathol; 2011 Feb; 33(1):60-4. PubMed ID: 21239898
[TBL] [Abstract][Full Text] [Related]
14. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
Esufali S; Bapat B
Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
[TBL] [Abstract][Full Text] [Related]
15. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
[TBL] [Abstract][Full Text] [Related]
16. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
Asally M; Yoneda Y
Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
[TBL] [Abstract][Full Text] [Related]
17. beta-Catenin expression in the transitional cell zone of pilomatricoma.
Park SW; Suh KS; Wang HY; Kim ST; Sung HS
Br J Dermatol; 2001 Oct; 145(4):624-9. PubMed ID: 11703290
[TBL] [Abstract][Full Text] [Related]
18. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas.
Xia J; Urabe K; Moroi Y; Koga T; Duan H; Li Y; Furue M
J Dermatol Sci; 2006 Jan; 41(1):67-75. PubMed ID: 16378715
[TBL] [Abstract][Full Text] [Related]
19. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis.
Jung HC; Kim K
Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of beta-catenin, E-cadherin, cyclin D1 and c-myc in benign trichogenic tumors.
Demirkan NC; Bir F; Erdem O; Düzcan E
J Cutan Pathol; 2007 Jun; 34(6):467-73. PubMed ID: 17518774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
